WOOLF TOD M has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SYLENTIS SAU, WELGENE INC and ROSSI JOHN J.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Computer technology | |
#5 | Electrical machinery and energy | |
#6 | Medical technology | |
#7 | Packaging and shipping | |
#8 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Woolf Tod M | 16 |
#2 | Lebedev Alexandre | 4 |
#3 | Hogrefe Richard I | 4 |
#4 | Marks Andrew S | 3 |
#5 | Khvorova Anastasia | 2 |
#6 | Kamens Joanne | 2 |
#7 | Salomon William | 2 |
#8 | Wachler Glenn | 1 |
#9 | Neumann Scott | 1 |
#10 | Woolf Scott | 1 |
Publication | Filing date | Title |
---|---|---|
CN109414449A | Using with do not utilize the improved method that can design nuclease editor's genome | |
EP3230445A2 | Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides | |
US2012059046A1 | Inhibition of MAP4K4 through RNAI | |
US2008297475A1 | Input Device Having Multifunctional Keys | |
US2011161054A1 | Systems and methods for computer aided inventing | |
US2006009409A1 | Double-stranded oligonucleotides |